chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Pruritus, Rash vesicular, Urticaria
Clinical narrative: This spontaneous report as received from a consumer refers to a 63 year old female patient. Concurrent conditions included high cholesterol and sulfa allergy. On 21-MAY-2013 the patient was vaccinated with ZOSTAVAX. Lot number, dose, route and frequency were not provided. Concomitant therapies included Simvastatin (manufacturer unknown). On 28-MAY-2013, reported as one week after administration, the patient experienced zoster like rash on her head, waist, arms, and back welts on her head, redness at the injections site and itchiness. The patient visited medical offices on unspecified dates. The patient stated she was prescribed Prednisone (manufacturer unknown), Betamethasone Valerate foam (manufacturer unknown), Locoid lipocream (manufacturer unknown), Hydroxizine hcl 25 mg (manufacturer unknown), Trimacinolone (manufacturer unknown) and Clobetasol (manufacturer unknown). The outcome of itchiness, redness at the injections site, zoster like rash on her head, waist, arms, and back and welts on her head was reported as not recovered/not resolved. The reporter causality was unknown. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report was received from a patient's wife refers to her husband of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiry not reported). On an unknown date, the patient developed shingles after receiving ZOSTAVAX. The outcome of shingles was unknown. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a licensed practical nurse concerning a patient of unknown age and gender. On 14-JUL-2004, the patient was vaccinated with the first dose of 0.5 milliliter (ml) of M-M-R II (lot number and expiry date unspecified), subcutaneously. On 15-OCT-2013, the patient was vaccinated with an expired dose of 0.5 ml (second dose) of M-M-R II (lot number and expiry date were reported as 1374AA and 26-AUG-2013 respectively), subcutaneously. No concomitant therapy was reported. No adverse effects were reported. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a female patient of unknown age who is also a Registered Nurse. On 09-OCT-2013, the patient received an expired dose of MMR II with an expiration date of 26-AUG-2013 (lot# not reported). No adverse effect was reported. Additional information is not expected.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Injection site warmth
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 66 year old female patient. On 01-OCT-2013, the patient was vaccinated with a dose of PNEUMOVAX23 lot # J006921, expiry date 09-AUG-2014. On an unknown date in 2013, the patient experienced injection site reaction that she described as soreness in her arm and warm to touch and soreness in her arm and warm to touch. No treatment was rendered for the events. The outcome of the events were reported as recovering. The patient was scheduled for a follow up appointment. This is one of the 3 reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 17-SEP-2013 the patient was vaccinated with MMR II (lot # H015829, expiration date 24-AUG-2014). The vaccines was exposed to temperature exposures of 52F, on 29-AUG-2013 for 40 minutes, on 09-SEP-2013 for 1 hr and 25 minutes, on 10-SEP-2013 for 15 minutes and on 17-SEP-2013 for 35 minutes. No known adverse effects. This case is linked to case 1310USA008360, 1310USA008361, 1310USA008362, 1310USA008363, 1310USA008364, 1310USA008365, 1310USA008366, 1310USA008367, 1310USA008368, 1310USA008369, 1310USA008370, 1310USA008371, 1310USA008372, 1310USA008373, 1310USA008374, 1310USA008375, 1310USA008376, 1310USA008377, 1310USA008378, 1310USA008379, 1310USA008380, 1310USA008381, 1310USA008382, 1310USA008383, 1310USA008384, 1310USA008385, 1310USA008386, 1310USA008387, 1310USA008388, 1310USA008389, 1310USA008390, 1310USA008391, 1310USA008392, 1310USA008393, 1310USA008394, 1310USA008395, 1310USA008396, 1310USA008397, 1310USA008398, 1310USA008399, 1310USA008400, 1310USA008401, 1310USA008402, 1310USA008403, 1310USA008404, 1310USA008405, 1310USA008406 and 1310USA008407 (same reporter linked. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 17-SEP-2013 the patient was vaccinated with M-M-R II (lot # H015829, expiration date 24-AUG-20140. The vaccine was exposed to temperature of 52F, on 29-AUG-2013 for 40 minutes, on 09-SEP-2013 for 1 hr and 25 minutes, on 10-SEP-2013 for 15 minutes and on 17-SEP-2013 for 35 minutes. No known adverse effects. This case is linked to case 1310USA008366, 1310USA008367,  1310USA008368, 1310USA008369, 1310USA008370, 1310USA008371, 1310USA008372, 1310USA008373, 1310USA008374, 1310USA008375, 1310USA008376, 1310USA008377, 1310USA008378, 1310USA008379, 1310USA008380, 1310USA008381, 1310USA008382, 1310USA008383, 1310USA008384, 1310USA008385, 1310USA008386, 1310USA008387, 1310USA008388, 1310USA008389, 1310USA008390, 1310USA008391, 1310USA008392, 1310USA008393, 1310USA008394, 1310USA008395, 1310USA008396, 1310USA008397, 1310USA008398, 1310USA008399,1310USA008400,  1310USA008401, 1310USA008402, 1310USA008403,1310USA008404,  1310USA008405, 1310USA008406 and 1310USA008407 (same reporter linked). Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Nurse practitioner (also reported degree Pharmacist doctor) who refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of GARDASIL lot # J004197 expiration date 27-NOV-2015 (route and dose were not reported)that was stored as low 29F for about 6 days. No adverse effect reported. Additional information has been requested.
Sex: M
Vaccine: PPV
Symptoms: Influenza like illness
Clinical narrative: This spontaneous report as received from a registered pharmacist refers to a male patient of unknown age. ON an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route and lot # not reported) and a dose of FLUZONE (dose, route and lot # not reported). The pharmacist reported that on an unknown date, the patient experienced flu like symptoms for one day. The patient did not receive treatment for the adverse event. The patient did not seek medical attention. The outcome of flu like symptoms was reported as recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients. On an unknown date, the unspecified number of patients were vaccinated with VARIVAX. On an unknown date, the patients may have received improperly stored of VARIVAX. No adverse event was reported. Additional information is not expected.
Age: 0.16
Sex: U
Vaccine: RV5
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to a 8 week old patient. On 15-OCT-2013 the patient was vaccinated with ROTATEQ (oral, 2 ml, dose 1, lot # 0380AE EXP 30-SEP-2013). The patient was administered an expired ROTATEQ no adverse effects reported. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a female patient of unknown age. In August 2012, the patient was vaccinated with the first dose of GARDASIL (route and lot # not reported) and in August 2013, the patient received the second dose of GARDASIL (route and lot # not reported). No adverse effect was reported. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Immediate post-injection reaction, Injection site rash
Clinical narrative: This spontaneous report was received from a nurse via company representative referring to a 5 year old female patient who in August 2013, vaccinated with PROQUAD (Merck) (lot # J005179, expiration date 03-NOV-2014). In A2013 the patient experienced developed a rash around the injection site. The outcome of developed a rash around the injection site was reported as recovered/resolved. {Additional information has been requested. / Additional information is not expected.} The nurse reported that the patient developed a rash around the injection site immediately after she received PROQUAD (Merck) in August 2013, and was given BENADRYL (dosage unspecified) in office and the rash went away the same day. Additional information is not expected.
Age: 24.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella virus test negative
Clinical narrative: This spontaneous report was received from a 24 year old female patient regarding herself. The patient didn't have pertinent medical history, drug reactions or allergies. On an unknown date, when the patient was a child, she was vaccinated with VARIVAX for prevention of chickenpox. Concentration, duration and route of administration were not reported. There were no concomitant medications. In October, 2011, her blood titer was negative for immunity to varicella virus and the patient present status had not changed since the blood titer. The outcome of the event was unknown. The relatedness between the adverse event and VARIVAX was not reported. Additional information is not expected.
Age: 69.0
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information has been received from a pharmacist concerning a 69 year old patient of unknown gender who on 16-SEP-2013 was vaccinated with a 0.5 ml dose of PNEUMOVAX23 lot # 672074/1502AA, Exp date 19-MAY-2013, intramuscular. No adverse effects reported. This is one of several reports received from the same source. Cases linked: 1310USA008719 and 1309USA009508. Additional information has been requested.
Age: 53.0
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information has been received from a pharmacist concerning a 53 year old patient of unknown gender who on 16-SEP-2013 was vaccinated with a 0.5 ml dose of PNEUMOVAX23 lot # 672074/1502AA, Exp date 19-MAY-2013, intramuscular. No adverse effects reported. This is one of several reports received from the same source. Cases linked: 1310USA008719 and 1310USA008720. Additional information has been requested.
Age: 60.0
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information has been received from a pharmacist concerning a 60 year old patient who on 16-SEP-2013 was vaccinated with a 0.5 ml dose of PNEUMOVAX23 lot # 672074/1502AA, Exp date 19-MAY-2013, intramuscular. No adverse effects reported. This is one of several reports received from the same source. Cases linked: 1309USA009508 and 1310USA008720. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Loss of consciousness, Presyncope
Clinical narrative: This spontaneous report has been received from a pharmacist via company representative concerning to a male patient of unknown age. Current conditions, medical history and drug reactions/allergies unspecified by reporter. On an unknown date, the patient was vaccinated with ZOSTAVAX (dose, lot# and route not provided). Concomitant medication was not reported. On an unknown date, the patient experienced a vaso-vagal reaction and "passed out". None laboratory diagnostics studies performed. The patient did not require any treatment for the adverse events. The patient recovered fully while in the pharmacy. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a 61 year old female consumer concerning herself. There was no pertinent medical history and no drug reactions/allergies. On 08-OCT-2013 the patient was vaccinated with ZOSTAVAX, (lot number and expiration date unknown), one time vaccine, dose and route unspecified in the left arm. There were no concomitant medications reported. On 12-OCT-2013, the patient broke out in shingles on her left arm which traveled down to her lymph node by her breast. The patient sought medical attention on 14-OCT-2013 and acyclovir 800mg was prescribed as antiviral medication. No labs diagnostic tests were performed. The outcome of broke out in shingles on her left arm which traveled to her lymph node by her breast was reported as recovering/resolving (also reported as the event did not improved). Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report has been from a medical assistant concerning to an "unspecified number of unspecified patients" of unknown age and gender. Current conditions, medical history and drug reactions/allergies were not reported. In 2013, the group of patients were vaccinated with VARIVAX lot # H018456, expiration date: 09-OCT-2013, (dose, frequency and route not reported). Concomitant medication was not reported. Since March 2013, a physician's office had numerous temperature excursions involving VARIVAX that were administered to an unspecified number of unspecified patients. The reported stated that the vaccine had multiple excursions between 6F and 14F totaling 248 hours between March-2013 and September-2013. The reporter also stated that the vaccine had multiple excursions between the range of 15F to 35F with a total of hours of 140 hours at refrigerator temperature: from March 2013 to July 2013 with the last excursion occurring on 16-JUL-2013. The stability data showed that VARIVAX was supported for one month. The reported stated that the vaccine had not been administered to any patients since 16-AUG-2013, so no adverse event occurred. No adverse effect reported. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Local swelling, Pruritus
Clinical narrative: I have enclosed 2 different copies. I had requested the flu vaccine not have the preservative as I have the following for 2 weeks severe itching. Swelling in size as large as a baseball I believe I was not given the right vaccine, as I had the same reaction as the above and went back to CVS to show them my right arm.
Age: 17.0
Sex: M
Vaccine: TDAP
Symptoms: Back pain, Blood immunoglobulin G, Blood immunoglobulin M, Borrelia test negative, Hypoaesthesia
Clinical narrative: 10/1/13 PM - onset of lower back pain, urinary retention and bilateral leg numbness, vomiting x 2. 10/2/13 0900 - to ER -> another ER MRI results - transverse myelitis.
Age: 17.0
Sex: M
Vaccine: TDAP
Symptoms: Influenza A virus test negative, Lumbar puncture normal, Mycoplasma test, Myelitis transverse, Nuclear magnetic resonance imaging abnormal
Clinical narrative: 10/1/13 PM - onset of lower back pain, urinary retention and bilateral leg numbness, vomiting x 2. 10/2/13 0900 - to ER -> another ER MRI results - transverse myelitis.
Age: 17.0
Sex: M
Vaccine: TDAP
Symptoms: Urinary retention, Vomiting, West Nile virus test negative
Clinical narrative: 10/1/13 PM - onset of lower back pain, urinary retention and bilateral leg numbness, vomiting x 2. 10/2/13 0900 - to ER -> another ER MRI results - transverse myelitis.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Hyperaesthesia, Induration, Local swelling, Tenderness
Clinical narrative: My entire upper arm swelled, turned red and became hard to touch. Was very tender and sensitive to touch for 3 days after administration.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Erythema, Induration, Pain, Skin discolouration, Swelling
Clinical narrative: LAT swollen, hard and red. Very painful for my son. Red area was approximately 2 inches morning of 10/15/2013. By next day, read area had increased to 4-5 inches in width. I have photos with ruler if you like. Now, on 10/18/2013, redness is subsiding but his skin is discolored and he still has a large hard area. He has had NO previous problem with any vaccines.  No treatment other than cold pack for his comfort at home because it is impossible to get through staff to contact/be seen by pediatrician, and the med group's urgent care is horrible (For instance, I was gravely ill from electrolyte imbalance when they repeatedly refused treatment to me during a viral illness.)
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Chronic fatigue syndrome, Dermatitis, Fatigue, Fibromyalgia, Intervertebral disc degeneration
Clinical narrative: Severe fatigue lasting at least two weeks prior to onset date above in combination with aches across the entire body, wide spread severe pain and inflammation up the skin and superficial muscles. I have been seeing doctors ever since trying to get well. Diagnosed with Fibromyalgia, Chronic Fatigue Syndrome, Chronic Pain Syndrome, degenerative discs and Central Sleep Apnea to date.
Age: 22.0
Sex: F
Vaccine: MNQ
Symptoms: Myositis, Pain, Pain of skin, Sleep apnoea syndrome
Clinical narrative: Severe fatigue lasting at least two weeks prior to onset date above in combination with aches across the entire body, wide spread severe pain and inflammation up the skin and superficial muscles. I have been seeing doctors ever since trying to get well. Diagnosed with Fibromyalgia, Chronic Fatigue Syndrome, Chronic Pain Syndrome, degenerative discs and Central Sleep Apnea to date.
Age: 49.0
Sex: M
Vaccine: FLUX
Symptoms: Musculoskeletal pain, Myalgia, Pain
Clinical narrative: Shoulder pain, unable to lift without pain. Muscle tenderness and painful to touch.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Cough, Eye pruritus, Eye swelling, Hypoaesthesia oral
Clinical narrative: Swollen lips.   Tongue is numb.  Itchy and puffy eyes.   Coughing.   Runny nose.  Chills.  Ache.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Lip swelling, Pain, Rhinorrhoea
Clinical narrative: Swollen lips.   Tongue is numb.  Itchy and puffy eyes.   Coughing.   Runny nose.  Chills.  Ache.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Heart rate increased
Clinical narrative: Fast heartbeat for 9-10 hours.
Age: 12.0
Sex: M
Vaccine: FLU4
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: Fever body aches generalized malaise.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Back pain, Chest X-ray normal, Chest discomfort, Dysphonia
Clinical narrative: Hives on torso, arms, and legs - itching.  Next day throat closing.  Weak - heaviness in chest, back pain.  Hoarseness.  Took aspirin and benadryl.  Next day went to dr.'s office, from there by ambulance to ER for 3 hours.  More meds - sent home with prescription for EpiPen, Prednisone, and Famotidine.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Electrocardiogram, Pruritus, Throat tightness, Urticaria
Clinical narrative: Hives on torso, arms, and legs - itching.  Next day throat closing.  Weak - heaviness in chest, back pain.  Hoarseness.  Took aspirin and benadryl.  Next day went to dr.'s office, from there by ambulance to ER for 3 hours.  More meds - sent home with prescription for EpiPen, Prednisone, and Famotidine.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, RV5
Symptoms: Haematochezia, Occult blood positive
Clinical narrative: Bloody stools.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, RV5
Symptoms: Haematochezia
Clinical narrative: Bloody stools.
Age: 52.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Local swelling
Clinical narrative: ARM TURNED SWOLLEN AND RED.
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: Headache, Paraesthesia, Syncope
Clinical narrative: PATIENT GOT FAINT.  SHE LAID DOWN AND WAS GIVEN FLUIDS AND FOOD.  SHE COMPLAINED OF A SEVERE HEADACHE AND TINGLING IN HER HANDS AND FEET.  BLOOD PRESSURE AND PULSE WERE NORMAL.  SHE WAS GIVEN IBUPROFEN 10 MG/KG X 1.  AFTER 45 MINUTES, SHE FELT WELL ENOUGH TO GO HOME BUT STILL COMPLAINED OF HEADACHE.  EXTREMITY TINGLING RESOLVED PRIOR TO DISCHARGE.
Age: 63.0
Sex: M
Vaccine: FLUX
Symptoms: Chills, Pyrexia
Clinical narrative: Severe chills, shivering, and high fever.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Pharyngeal oedema
Clinical narrative: My throat began to swell.
Age: 1.39
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: My doctor asked me if I would like a flu shot for my son and I said yes. The doctor was aware of my sons slight cold symptoms and still offered the shot. The nurse who gave my son the shot also noticed my son had a slight cough and she still proceeded with the vaccination.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Somnolence
Clinical narrative: Patient reports extreme fatigue and drowsiness.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Myalgia
Clinical narrative: Patient received vaccination on 9/20/2013 in left deltoid muscle.  Muscle soreness was "normal" for first few days and decreased to the point where the pain was almost gone.  On approximately 10/09/2013 the soreness began to get worse and progressed to the point where the patient was unable to lift her arm above her head on the morning of 10/19/2013.  This prompted her to call us at the pharmacy.  According to the patient there are no other symptoms; no redness, no bruising, no other sore muscles.  Patient also denies any new or out of the ordinary activities at the time the muscle soreness worsening.  The only factors she could have attributed the soreness to was the weather getting colder.  The patient has not seeked medical attention yet, but plans to if the pain does not go away within the next week.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Patient has experienced increased muscle pain at the site of the injection beginning roughly 3 weeks after the vaccination was received.  Muscle pain/soreness was "normal" for first few days following vaccination on 9/20/2013, and the soreness was almost completely gone until around 10/09/2013.  The patients wife is also experiencing this, however her situation is more severe.  Patient's situation is manageable.  No other contributing factors such as new activities causing soreness.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site inflammation
Clinical narrative: Patient complained of inflammation at the injection site. No hives, swelling of the lips or tongue or difficulty breathing.
Age: 3.0
Sex: F
Vaccine: FLU4
Symptoms: Electrocardiogram, Immunoglobulin therapy, Kawasaki's disease
Clinical narrative: Kawasaki disease 700ml IVIG.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Patient developed redness and swelling at the injection site along with pain and itchiness.
Age: 74.0
Sex: M
Vaccine: RAB
Symptoms: Arthralgia, Asthenia, Dizziness, Fatigue, Headache
Clinical narrative: Patient received rabies immunoglobulin in glute and first rabies vaccine in deltoid on 7/1/13 with subsequent vaccines being received in the ED (2nd) and infusion center (3rd).  This in response to a bat bite to the right forearm on 7/3/13 in patient's bedroom with bat acting "not right".  Patient reported bilateral hamstring pain hours after the immunoglobulin injection worsening with each vaccine received and persisting for a month and a half.  Worsening symptoms included bilateral hamstring pain, stiffness, knee pain, headache, dizziness, weakness, fatigue (similar to severe flu), numbness in glutes and down back of legs.  Patient was seen by infectious disease for multiple follow ups and I was requested to report to MedWatch...redirected here.
Age: 74.0
Sex: M
Vaccine: RAB
Symptoms: Hypoaesthesia, Influenza like illness, Musculoskeletal stiffness, Myalgia
Clinical narrative: Patient received rabies immunoglobulin in glute and first rabies vaccine in deltoid on 7/1/13 with subsequent vaccines being received in the ED (2nd) and infusion center (3rd).  This in response to a bat bite to the right forearm on 7/3/13 in patient's bedroom with bat acting "not right".  Patient reported bilateral hamstring pain hours after the immunoglobulin injection worsening with each vaccine received and persisting for a month and a half.  Worsening symptoms included bilateral hamstring pain, stiffness, knee pain, headache, dizziness, weakness, fatigue (similar to severe flu), numbness in glutes and down back of legs.  Patient was seen by infectious disease for multiple follow ups and I was requested to report to MedWatch...redirected here.
Age: 40.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Dizziness, Injection site induration, Muscle swelling, Pain
Clinical narrative: Dizziness (light headed) for 15 minutes after injection.  BP was 115/78 and shot up to 129/84. Painful muscle swelling and stiffening around the injection site and the entire outer upper left arm that started at around 9:30pm.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Previous reaction reported: swelling anround the injection site and redness.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Lacrimation increased, Nasal congestion, Ocular hyperaemia, Pyrexia
Clinical narrative: Red and watery eyes, congestion in nose and fever.
Age: 0.21
Sex: F
Vaccine: DTAPHEPBIP, HIBV, RVX, UNK
Symptoms: Choking, Cough, Pyrexia, Respiratory syncytial virus test, Vomiting
Clinical narrative: Fever, cough, vomiting, choking.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Lip blister, Oral herpes, Pain
Clinical narrative: Very painful group of 4 blisters suddenly developed on my right upper lip. It is a herpes simplex cold sore. I have never had a cold sore in my life.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Dizziness, Fall
Clinical narrative: Suddenly while sitting started feeling dizzy-got up to go lie down-took a few steps and found myself sitting on the floor.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Activities of daily living impaired, Back pain, Chills, Erythema, Headache
Clinical narrative: 10/9/13: 11 am chills, body aches HA/backache, arm pain, took ADVIL Q4 Hrs. 10/10/13: Skipped work, could not lift arm. 5 pm arm was very red, warm, has swelling about 3-4 inches. 10/11/13: visited Dr. got SEPTRA DS BID x 10 days. 10/12/3 fever at 10 PM. 10/13/13: Starting feeling better AM.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site infection, Local swelling, Mobility decreased, Pain, Pain in extremity
Clinical narrative: 10/9/13: 11 am chills, body aches HA/backache, arm pain, took ADVIL Q4 Hrs. 10/10/13: Skipped work, could not lift arm. 5 pm arm was very red, warm, has swelling about 3-4 inches. 10/11/13: visited Dr. got SEPTRA DS BID x 10 days. 10/12/3 fever at 10 PM. 10/13/13: Starting feeling better AM.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pyrexia, Skin warm
Clinical narrative: 10/9/13: 11 am chills, body aches HA/backache, arm pain, took ADVIL Q4 Hrs. 10/10/13: Skipped work, could not lift arm. 5 pm arm was very red, warm, has swelling about 3-4 inches. 10/11/13: visited Dr. got SEPTRA DS BID x 10 days. 10/12/3 fever at 10 PM. 10/13/13: Starting feeling better AM.
Age: 30.0
Sex: U
Vaccine: FLU3
Symptoms: Blood pressure increased, Pyrexia, Urticaria
Clinical narrative: Low grade fever 99.1 degrees, increased blood pressure, hives, given antibiotics. All resolved in 48 hrs.
Age: 75.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Local swelling, Pain in extremity
Clinical narrative: Arm swelled and was painful.
Age: 60.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Headache, Injection site reaction, Insomnia, Lymphoedema, Pain
Clinical narrative: Within 10 hours of flu shot and pneumococcal shot pt. began to feel feverish, headache, body ache, nausea and could not sleep due to symptoms. Next AM blotchy rash around injection site, spreading both distally and medially with lymphedema. Pt. took aspirin for fever and TYLENOL PM with positive results. Symptoms lasted around 3 days.
Age: 60.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pyrexia, Rash macular
Clinical narrative: Within 10 hours of flu shot and pneumococcal shot pt. began to feel feverish, headache, body ache, nausea and could not sleep due to symptoms. Next AM blotchy rash around injection site, spreading both distally and medially with lymphedema. Pt. took aspirin for fever and TYLENOL PM with positive results. Symptoms lasted around 3 days.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Bone pain, Chills, Injection site pain, Local swelling, Mobility decreased
Clinical narrative: Pain and couldn't lift arm. Hurt to even touch her arm, 10+ left shoulder pain scale. Severe spasms and chills lasting about 12 hours next AM on 13th pain moved to elbow; still difficult to lift; sore to bone left hand swelling, pain collarbone.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Muscle spasms, Pain
Clinical narrative: Pain and couldn't lift arm. Hurt to even touch her arm, 10+ left shoulder pain scale. Severe spasms and chills lasting about 12 hours next AM on 13th pain moved to elbow; still difficult to lift; sore to bone left hand swelling, pain collarbone.
Age: 38.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Dizziness, Erythema, Pyrexia
Clinical narrative: Within 24hrs fever of 101.5. Red circle that grew for 72hrs. Antibiotics given. Dizzy. Fever resolved day 4 continuing to see reduced redness.
Age: 49.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site rash, Pyrexia
Clinical narrative: Fever, red rash around injection site, right arm where PNEUMOVAX given.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site pruritus
Clinical narrative: Local redness, itching, soreness and inflammation at sub-q injection site on left arm.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Axillary pain, Burning sensation, Injection site pain, Local swelling, Skin warm
Clinical narrative: Patient indicates pain in the area of the arm vaccinated, armpit, burning, swollen and hot. Right arm.
Age: 56.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Local swelling, Pain in extremity
Clinical narrative: Patient received FLUVIRIN 2013-2014 and PNEUMOVAX shots on same day in same arm. Patient reports swelling from shoulder to elbow accompanied with pain and redness.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Dysphagia, Ear pain, Pain in jaw
Clinical narrative: Patient reported difficulty swallowing and pain in jaw bone radiating to his ear (right side of face). Started feeling symptoms within 1 hour of injection. No trouble breathing or throat swelling reported.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Local swelling, Rash erythematous
Clinical narrative: Red, raised bumps located in the antecubital area of both arms and the lower extremities that appeared around 7 days after the vaccine.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dyspnoea, Immediate post-injection reaction, Injection site erythema, Injection site pruritus
Clinical narrative: Received intradermal vaccine (influenza). Immediately experienced shortness-of-breath, coughing and wheezing and redness and itching at site. Given 25mg BENADRYL and albuterol inhaler. Took a total of 2x 25mg BENADRYL.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: Received intradermal vaccine (influenza). Immediately experienced shortness-of-breath, coughing and wheezing and redness and itching at site. Given 25mg BENADRYL and albuterol inhaler. Took a total of 2x 25mg BENADRYL.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Immediate post-injection reaction, Pruritus, Urticaria
Clinical narrative: Received intradermal influenza vaccine. Immediately experienced localized itching and redness. Over the next few hours took a total of 5x 25mg BENADRYL. Went to urgent care that evening with systemic itching and urticaria. Given steroid injection and oral prednisone.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Red raised spot size of a dollar quarter. Warm to touch, sore to touch.
Age: 65.0
Sex: F
Vaccine: FLU4, PPV, PPV
Symptoms: Erythema, Local swelling
Clinical narrative: This spontaneous report was received from a doctor of pharmacy concerning an approximately a 65 year old female patient. Current conditions of the patient included high blood pressure, anxiety, codeine allergy, meperidine allergy, methadone allergy, propoxyphene allergy, naloxone allergy and opium alkaloids allergy. On 22-SEP-2013, the patient was vaccinated with a dose of PNEUMOVAX23 (lot number and expiry date were reported as H021941 and 11-JUL-2014 respectively , dose unspecified), intramuscularly. Concomitant therapies included amlodipine, meloxicam, alprazolam, and estazolam. Approximately on an unknown date in 2013, after the vaccination, the patient developed a small bump which formed under the skin at the site of the PNEUMOVAX23 injection. The patient sought medical attention (went to the pharmacy). No treatment was given and no lab tests were performed. The patient was snot recovered from the event at the time of report. The relatedness for the event was unknown for PNEUMOVAX23. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: FLU4, PPV, PPV
Symptoms: Injection site swelling
Clinical narrative: This spontaneous report was received from a doctor of pharmacy concerning an approximately a 65 year old female patient. Current conditions of the patient included high blood pressure, anxiety, codeine allergy, meperidine allergy, methadone allergy, propoxyphene allergy, naloxone allergy and opium alkaloids allergy. On 22-SEP-2013, the patient was vaccinated with a dose of PNEUMOVAX23 (lot number and expiry date were reported as H021941 and 11-JUL-2014 respectively , dose unspecified), intramuscularly. Concomitant therapies included amlodipine, meloxicam, alprazolam, and estazolam. Approximately on an unknown date in 2013, after the vaccination, the patient developed a small bump which formed under the skin at the site of the PNEUMOVAX23 injection. The patient sought medical attention (went to the pharmacy). No treatment was given and no lab tests were performed. The patient was snot recovered from the event at the time of report. The relatedness for the event was unknown for PNEUMOVAX23. Additional information has been requested.
Age: 68.0
Sex: U
Vaccine: FLU3, PPV, VARZOS
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a licensed practical nurse concerning an approximately a 68 year old patient of unknown gender. On 08-OCT-2013, the patient was vaccinated with an improperly stored dose of 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date were reported as J001007 and 24-APR-2014 respectively), subcutaneously in the left arm. Concomitant therapies included a dose of PNEUMOVAX23 (lot number, expiry date, dose and route unspecified) administered on 08-OCT-2013 in the right deltoid and a dose of FLUVIRIN (lot number, expiry date, dose and route unspecified) administered on 08-OCT-2013 in the right arm. No adverse effects were reported at the time of report. Additional information has been requested.
Sex: M
Vaccine: FLUX, PPV, VARZOS
Symptoms: Feeling abnormal, Pyrexia
Clinical narrative: This spontaneous report was received from a registered pharmacist via a company representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). Other suspect therapies included PNEUMOVAX23 (lot#, expiration date and route not reported) and influenza virus vaccine (manufacturer unknown). On an unknown date the patient experienced 104 degrees fever and complained of "not feeling good". Treatment was not rendered for the events. Medical attention was sought for the events by contacting the pharmacist. The events resolved on an unknown date. Causality was not reported. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous report was received from a female patient of unknown age with no pertinent medical history and drug reactions/allergies. On 13-OCT-2013 the patient was vaccinated with ZOSTAVAX (lot#, expiration date and route not reported). Concomitant therapies included Losartan Potassium and Hydrochlorothiazide tablets. On 13-OCT-2013, 2 days after onset of therapy the patient had injection site redness, swelling and warmth on 1-2 inches of skin in what she said looked like a bull's-eye'. Treatment information was not rendered for the events. No laboratory diagnostic studies were performed for the events. Medical attention was not sought. The outcome of the events were unknown. Causality was not reported. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Injection site erythema, Injection site warmth
Clinical narrative: This spontaneous report was received from a doctor of pharmacy refers to a 61 year old female patient no drug reactions/allergies. On 11-OCT-2013 the patient was vaccinated with 0.65 milliliter ZOSTEVAX (lot # J004267, expiration date 12-JUL-2014) subcutaneously. On 12-OCT-2103, 2 days after onset of therapy, the patient developed redness about "silver dollar size", "warm to touch" at the injection site and diarrhea. The pharmacist stated that the redness was down to "about quarter size now". Treatment was not rendered for the events. Laboratory diagnostic studies were not performed for the events. Medical attention was not sought. The outcome of diarrhea and warm to touch at the injections site was unknown. The outcome of redness about silver dollar size was reported as recovering/resolving. Causality was not reported. This is one of the several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to two patients of unknown age and gender. On 16-SEP-2013, the patients were vaccinated with a dose of PROQUAD (SDV, MDV or Additive) (lot# J006869, expiration date reported as 14-DEC-2014, dose and indication not reported), subcutaneous, which was an order received into the pharmacy and placed into the refrigerator at normal refrigeration temperatures of 36-46 degrees Fahrenheit(F). No known adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Incorrect dose administered, Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 1 year old patient of unknown gender. On 23-SEP-2013, the patient was vaccinated with a dose of PROQUAD (Merck) (lot # J006869, expiration date reported as 14-DEC-2014, dose and indication not reported), subcutaneous, which was an order received into the pharmacy and placed into the refrigerator at normal refrigeration temperatures of 36-46 degrees Fahrenheit (F) on 16-SEP-2013. The patient received PROQUAD (Merck) along with VARIVAX (Merck) (lot #, expiration date, dose, route and indication not reported) in error. No known adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Expired drug administered, Vomiting
Clinical narrative: This spontaneous report was received from a physician via a company representative concerning a 2 month old female patient with no pertinent medical history and no drug reactions and allergies. On 14-OCT-2013, the patient was vaccinated with an expired dose of 2 milliliter (ml) (first dose) of ROTATEQ (lot number and expiry date were reported as H010690 and 05-OCT-2013 respectively), orally. There were no concomitant medications. On 16-OCT-2013 (also reported as today), the patient experienced vomiting. Physician reported that no treatment was given due to the patient vomiting and no lab or diagnostic studies were performed. The outcome of vomiting was unknown. The relatedness was unknown for ROTATEQ. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 1 year old patient of unknown gender. On 26-SEP-2013, the patient was vaccinated with a dose of PROQUAD (Merck) (SDV, MDV or ADDITIVE) (lot # reported as J006869, expiration date reported as 14-DEC-2014, dose and indication not reported), subcutaneous, which was an order received into the pharmacy and placed into the refrigerator at normal refrigeration temperatures of 36-46 degrees Fahrenheit (F) on 16-SEP-2013. The patient received PROQUAD (Merck) along with VARIVAX (Merck) (lot #, expiration date, dose, route and indication not reported) in error. No known adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: This spontaneous report was received from a healthcare worker concerning an approximately 51 year old female patient. Current condition of the patient included hives to VICODIN. On 14-OCT-2013, the patient was vaccinated with 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date were reported as J002241 and 21-MAY-2014 respectively), subcutaneously in the left arm. Concomitant therapies included losartan and trazodone. Approximately on an unknown date in October 2013, the patient experienced redness and pain at the injection site, low grade fever and left axillary pain. The patient sought medical attention (office visit). The patient was advised to take MOTRIN and to apply ice locally. No further treatment was given at the time of report. No lab tests were performed. The patient was not recovered from the events at the time of report. The relatedness for the events was unknown for ZOSTAVAX. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose of ZOSTAVAX (lot #, expiration date, dose, frequency, route and indication not reported). On an unknown date, the patients revaccinated the second dose of ZOSTAVAX at an unspecified time 4 years after initial dose. No adverse effects were reported. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: This spontaneous report was received from a doctor of pharmacy via a company representative concerning a 62 year old female patient. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. On an unknown date, after the vaccination, the patient experienced a slightly elevated injection site reaction (unspecified) that was 6 inches in length. It was unspecified if the patient sought any medical attention. It was unspecified if any treatment was given or if any lab tests were performed. The patient was recovering from the event. The relatedness for the event was unknown for ZOSTAVAX. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 23-SEP-2013 the patient was vaccinated with MMR II (lot # H015829, expiration date 24-AUG-2014). The vaccine was exposed to temperature exposures of 52F, on 29-AUG-2013 for 40 minutes, on 09-SEP-2013 for 1 hr and 25 minutes, on 10-SEP-2013 for 15 minutes, 17-SEP-2013 for 35 minutes, on 19-SEP-2013 for 1 hour and 35 minutes and on 20-SEP-2013 for 40 minutes. No known adverse effects. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site cellulitis
Clinical narrative: This spontaneous report was received from a registered pharmacist via a company representative refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). On an unknown date the patient developed cellulitis at the injection site. The outcome of cellulitis at the ZOSTAVAX injection site was unknown. Causality was not reported. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ, HPV4, MEN
Symptoms: Death
Clinical narrative: Random headache, legs hurt, extreme fatigue, vomiting.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ, HPV4, MEN
Symptoms: Autopsy, Death
Clinical narrative: Random headache, legs hurt, extreme fatigue, vomiting.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ, HPV4, MEN
Symptoms: Fatigue, Headache, Pain in extremity, Vomiting
Clinical narrative: Random headache, legs hurt, extreme fatigue, vomiting.
Age: 4.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Fever 103.5, gave children's ibuprofen.
Age: 39.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Hives, itching and redness.
Age: 49.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccine area got swollen, red and felt hot. More than 24 hrs. later the area is getting worse. Swollen area is about 6 inches + and growing. Not sure if I might need to go to ER or wait to see my doctor.
Age: 39.0
Sex: M
Vaccine: SMALL
Symptoms: Amnesia, Angina pectoris, Bowel movement irregularity, CSF pressure increased, Chest pain
Clinical narrative: Decreased ability to exercise difficulty having a bowel movement (stool) difficulty with moving flushing or redness of the skin general feeling of discomfort or illness itching, pain, redness, or swelling at the vaccine site muscle aching or cramping muscle stiffness nausea rash swollen joints unusually warm skin  amnesia, confusion, disorientation, restlessness, delirium, drowsiness, seizures, urinary incontinence, urinary retention, constipation, meningismus and/or coma. Increased CSF pressure is present, but chemistry and cell count may be normal. Histopathological changes include perivenous demyelination, microglial proliferation in demyelinated areas with lymphocytic infiltration. atypical chest pain, angina, palpitations, Eczema vaccinatum. Serious skin rashes caused by widespread infection of the skin in people with skin conditions such as eczema or atopic dermatitis. necrosis of the inoculation site pictures are available.  With this noticeable reactions in front of the immunization staff they were convinced that i was ok to proceed to anthrax and meningococcal vaccines on july 27 2013 on top of my already reaction. I felt i was dragged. I attempted to get help but this is no clinic to handle adverse reactions.  I have been hypochondriac and skin red spots comes and goes arthritis pain feeling bouncing pains on off from joint to other places. I feel tire and out of space all the time over three months now. I can get back to where i was.  I have pictures of possible spread of the virus on neck inner thighs...